Clinical trial
Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting…
NCT00287027 · National Alliance on Mental Illness New Hampshire, Other · Terminated
Key facts
| NCT number | NCT00287027 |
|---|---|
| Title | Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication |
| Official title | Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication |
| Lead sponsor | National Alliance on Mental Illness New Hampshire, Other |
| Collaborators | Janssen Medical Affairs Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Psychotic Disorders |
| Intervention type | Drug |
| Interventions | Risperdal Long Acting Injectable Antipsychotic Medication |
| Enrollment | 60 |
| Start date | Feb 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Feb 6, 2006 |
| Last update posted | Jan 5, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: